Oral candidiasis natural history, complications and prognosis: Difference between revisions
Created page with "__NOTOC__ {{Oral candidiasis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{Refli..." |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oral candidiasis}} | {{Oral candidiasis}} | ||
{{CMG}} | |||
==Natrual History, Complications and Prognosis== | |||
There are no sequela with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the mortality rate is almost 50%. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs | [[Category:Needs ovcerview]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] |
Revision as of 20:25, 26 November 2012
Oral candidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral candidiasis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Oral candidiasis natural history, complications and prognosis |
FDA on Oral candidiasis natural history, complications and prognosis |
CDC on Oral candidiasis natural history, complications and prognosis |
Oral candidiasis natural history, complications and prognosis in the news |
Blogs on Oral candidiasis natural history, complications and prognosis |
Risk calculators and risk factors for Oral candidiasis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Natrual History, Complications and Prognosis
There are no sequela with appropriate antifungal therapy. In contrast, among immunocompromised patients with disseminated infections, the mortality rate is almost 50%.